skip to main content
Idioma:
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Elsevier ScienceDirect Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
1-Deoxynojirimycin attenuates high glucose-accelerated senescence in human umbilical vein endothelial cells
1-Deoxynojirimycin attenuates high glucose-accelerated senescence in human umbilical vein endothelial cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

1-Deoxynojirimycin attenuates high glucose-accelerated senescence in human umbilical vein endothelial cells

E., Shuang ; Kijima, Ryo ; Honma, Taro ; Yamamoto, Kazushi ; Hatakeyama, Yu ; Kitano, Yasuna ; Kimura, Toshiyuki ; Nakagawa, Kiyotaka ; Miyazawa, Teruo ; Tsuduki, Tsuyoshi

Experimental gerontology, 2014-07, Vol.55, p.63-69 [Periódico revisado por pares]

England: Elsevier Inc

Texto completo disponível

Citações Citado por
2
1013 IMPACT OF NEWLY DEVELOPED HIGH-SENSITIVE (I-FETOPROTEIN-L3 FRACTION ASSAY ON THE DIAGNOSIS AND TREATMENT EVALUATION OF HEPATOCELLULAR CARCINOMA
1013 IMPACT OF NEWLY DEVELOPED HIGH-SENSITIVE (I-FETOPROTEIN-L3 FRACTION ASSAY ON THE DIAGNOSIS AND TREATMENT EVALUATION OF HEPATOCELLULAR CARCINOMA
Material Type:
Artigo 		Adicionar ao Meu Espaço

1013 IMPACT OF NEWLY DEVELOPED HIGH-SENSITIVE (I-FETOPROTEIN-L3 FRACTION ASSAY ON THE DIAGNOSIS AND TREATMENT EVALUATION OF HEPATOCELLULAR CARCINOMA

Tateishi, R ; Nakagawa, H ; Shiina, S ; Enooku, K ; Mikami, S ; Sato, M ; Uchino, K ; Arano, T ; Masuzaki, R ; Goto, E ; Kondo, Y ; Goto, T ; Fujie, H ; Ikeda, H ; Omata, M ; Yoshida, H ; Koike, K

Journal of hepatology, 2011-03, Vol.54, p.S403-S403 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
3
1025P DOcetaxel (DOC) plus RAmucirumab (RAM) with pegylated Granulocyte-colONy stimulating factor (PEG-G-CSF) for elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trial (DRAGON study: WJOG9416L)
1025P DOcetaxel (DOC) plus RAmucirumab (RAM) with pegylated Granulocyte-colONy stimulating factor (PEG-G-CSF) for elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trial (DRAGON study: WJOG9416L)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1025P DOcetaxel (DOC) plus RAmucirumab (RAM) with pegylated Granulocyte-colONy stimulating factor (PEG-G-CSF) for elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trial (DRAGON study: WJOG9416L)

Tokito, T. ; Hata, A. ; Hara, S. ; Tachihara, M. ; Okada, H. ; Tanaka, H. ; Sato, Y. ; Tabata, E. ; Watanabe, H. ; Takayama, Y. ; Toyozawa, R. ; Okamoto, I. ; Wakuda, K. ; Nakamura, A. ; Shimokawa, M. ; Yamamoto, N. ; Nakagawa, K.

Annals of oncology, 2022-09, Vol.33, p.S1023-S1024 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
1047 Visceral obesity is a useful predictor of better recurrence-free survival after curative surgeries for Japanese patients with localized clear cell renal cell carcinoma
1047 Visceral obesity is a useful predictor of better recurrence-free survival after curative surgeries for Japanese patients with localized clear cell renal cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

1047 Visceral obesity is a useful predictor of better recurrence-free survival after curative surgeries for Japanese patients with localized clear cell renal cell carcinoma

Kaneko, G ; Miyajima, A ; Hasegawa, M ; Mizuno, R ; Uchida, Y ; Hara, S ; Kikuchi, E ; Nakagawa, K ; Jinzaki, M ; Oya, M

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e1047-e1047a

Elsevier B.V

Texto completo disponível

Citações Citado por
5
1109 Does laparoendoscopic single-site adrenalectomy in patients with unilateral pheochromocytoma increase surgical risk? A case control study
1109 Does laparoendoscopic single-site adrenalectomy in patients with unilateral pheochromocytoma increase surgical risk? A case control study
Material Type:
Artigo 		Adicionar ao Meu Espaço

1109 Does laparoendoscopic single-site adrenalectomy in patients with unilateral pheochromocytoma increase surgical risk? A case control study

Maeda, T ; Miyajima, A ; Kikuchi, E ; Hasegawa, M ; Yasumizu, Y ; Kaneko, G ; Kosaka, T ; Nakagawa, K ; Oya, M

European urology supplements : official journal of the European Association of Urology, 2012-02, Vol.11 (1), p.e1109-e1109a

Elsevier B.V

Texto completo disponível

Citações Citado por
6
1225OOVERALL AND INTRACRANIAL (IC) EFFICACY RESULTS AND TIME TO SYMPTOM DETERIORATION IN PROFILE 1014: 1ST-LINE CRIZOTINIB VS PEMETREXED − PLATINUM CHEMOTHERAPY (PPC) IN PATIENTS (PTS) WITH ADVANCED ALK-POSITIVE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
1225OOVERALL AND INTRACRANIAL (IC) EFFICACY RESULTS AND TIME TO SYMPTOM DETERIORATION IN PROFILE 1014: 1ST-LINE CRIZOTINIB VS PEMETREXED − PLATINUM CHEMOTHERAPY (PPC) IN PATIENTS (PTS) WITH ADVANCED ALK-POSITIVE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1225OOVERALL AND INTRACRANIAL (IC) EFFICACY RESULTS AND TIME TO SYMPTOM DETERIORATION IN PROFILE 1014: 1ST-LINE CRIZOTINIB VS PEMETREXED − PLATINUM CHEMOTHERAPY (PPC) IN PATIENTS (PTS) WITH ADVANCED ALK-POSITIVE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)

Solomon, B ; Felip, E ; Blackhall, F.H ; Mok, T.S.K ; Kim, D ; Wu, Y ; Nakagawa, K ; Mekhail, T ; Paolini, J ; Usari, T ; Iyer, S ; Reisman, A ; Wilner, K ; Tursi, J ; Cappuzzo, F

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv427-iv427 [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
7
1226PDIMPACT OF CRIZOTINIB ON PATIENT-REPORTED SYMPTOMS AND GLOBAL QUALITY OF LIFE (QOL) COMPARED WITH PLATINUM BASED CHEMOTHERAPY IN PHASE III STUDY OF TREATMENT NAïVE ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC)
1226PDIMPACT OF CRIZOTINIB ON PATIENT-REPORTED SYMPTOMS AND GLOBAL QUALITY OF LIFE (QOL) COMPARED WITH PLATINUM BASED CHEMOTHERAPY IN PHASE III STUDY OF TREATMENT NAïVE ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1226PDIMPACT OF CRIZOTINIB ON PATIENT-REPORTED SYMPTOMS AND GLOBAL QUALITY OF LIFE (QOL) COMPARED WITH PLATINUM BASED CHEMOTHERAPY IN PHASE III STUDY OF TREATMENT NAïVE ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC)

Blackhall, F ; Felip, E ; Cappuzzo, F ; Kim, D.W ; Wu, Y ; Solomon, B ; Nakagawa, K ; Mekhail, T ; Paolini, J ; Usari, T ; Iyer, S ; Reisman, A ; Wilner, K ; Tursi, J ; Mok, T

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv428-iv428 [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
8
1294P RELAY, erlotinib plus ramucirumab or placebo in untreated EGFR-mutated metastatic NSCLC: Outcomes by EGFR mutation type
1294P RELAY, erlotinib plus ramucirumab or placebo in untreated EGFR-mutated metastatic NSCLC: Outcomes by EGFR mutation type
Material Type:
Artigo 		Adicionar ao Meu Espaço

1294P RELAY, erlotinib plus ramucirumab or placebo in untreated EGFR-mutated metastatic NSCLC: Outcomes by EGFR mutation type

Nakagawa, K. ; Nadal, E. ; Garon, E.B. ; Nishio, M. ; Seto, T. ; Yamamoto, N. ; Park, K. ; Shih, J-Y. ; Frimodt-Moller, B. ; Zimmermann, A.H. ; Visseren-Grul, C.M. ; Reck, M.

Annals of oncology, 2020-09, Vol.31, p.S838-S838 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
9
1298P RELAY, ramucirumab plus erlotinib (RAM+ERL) versus placebo plus erlotinib (P+ERL) in untreated EGFR mutated metastatic non-small cell lung cancer (NSCLC): Exposure-response relationship
1298P RELAY, ramucirumab plus erlotinib (RAM+ERL) versus placebo plus erlotinib (P+ERL) in untreated EGFR mutated metastatic non-small cell lung cancer (NSCLC): Exposure-response relationship
Material Type:
Artigo 		Adicionar ao Meu Espaço

1298P RELAY, ramucirumab plus erlotinib (RAM+ERL) versus placebo plus erlotinib (P+ERL) in untreated EGFR mutated metastatic non-small cell lung cancer (NSCLC): Exposure-response relationship

Nakagawa, K. ; Garon, E. ; Gao, L. ; Callies, S. ; Zimmermann, A. ; Walgren, R. ; Visseren-Grul, C. ; Reck, M.

Annals of oncology, 2020-09, Vol.31, p.S839-S840 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
10
137: Impact of Vascular Endothelial Growth Factor on Regeneration of the Bladder Acellular Matrix Graft; Histologic and Functional Evaluation
137: Impact of Vascular Endothelial Growth Factor on Regeneration of the Bladder Acellular Matrix Graft; Histologic and Functional Evaluation
Material Type:
Artigo 		Adicionar ao Meu Espaço

137: Impact of Vascular Endothelial Growth Factor on Regeneration of the Bladder Acellular Matrix Graft; Histologic and Functional Evaluation

Urakami, Shinji ; Shiina, Hiroaki ; Izumo ; Enokida, Hideki ; Youssif, Mohamed E. ; Fandel, Thomas ; Greene, Kirsten L. ; Nunes, Lora ; Gleason, Curtis ; Nakagawa, Masayuki ; lgawa, Mikio ; Dahiya, Rajvir ; Tanagho, Emil A.

The Journal of urology, 2005-04, Vol.173 (4), p.37-37 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (845)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (865)
  2. Anais de Congresso  (9)
  3. Book Chapters  (5)
  4. Web Resources  (1)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1975  (17)
  2. 1975Até1987  (39)
  3. 1988Até1998  (190)
  4. 1999Até2010  (323)
  5. Após 2010  (312)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (860)
  2. Japonês  (170)
  3. Português  (12)
  4. Espanhol  (5)
  5. Francês  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.